Consultant and Head of Hematology Department at Burjeel Medical City since December 2021, UAE.

He is a member of the Board of Directors of the Dubai Health Authority , Abu Dhabi Health Services Company ( SEHA ), and a member of the American Society of Hematology, the Emirates Society of Hematology, and the Saudi Society of Hematology.

He worked as a consultant in hematology at both Sheikh Shakhbout Medical City between 2021 and 2022, and Sheikh Khalifa Medical City between April 2015 and August 2022. He also held the position of Vice President of Quality at the same entity between November 2016 and March 2018, and Consultant and Head of the Hematology Department at the Dubai Health Authority between July 1999 and March 2015.

He established the Hematology Unit at Dubai Hospital , and was part of the team that performed the first bone marrow transplant in the UAE in 2019.

He has over 23 years of experience in hematology, hemoglobinopathies, thrombosis, bleeding disorders, leukemia, lymphoma, and post bone marrow transplant follow-up.

He obtained the American Board of Medical Quality in 2014, the American and Canadian Board of Hematology in 2007, the Canadian Board of Internal Medicine in 2006, the American Board of Internal Medicine in 2005, in addition to a fellowship in autologous bone marrow transplantation in 2008 from McMaster University in Canada.

Bachelor of Medicine and Surgery 1999 from the Royal College of Surgeons in Ireland.